Urabe, S., Isomoto, H., Ishida, T., Maeda, K., Inamine, T., Kondo, S., . . . Tsukamoto, K. (2015). Genetic Polymorphisms of IL-17F and TRAF3IP2 Could Be Predictive Factors of the Long-Term Effect of Infliximab against Crohn's Disease. BioMed Research International, 2015, 1-13.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita Chicago Style (17a ed.)
Urabe, Shigetoshi, et al. "Genetic Polymorphisms of IL-17F and TRAF3IP2 Could Be Predictive Factors of the Long-Term Effect of Infliximab Against Crohn's Disease."
BioMed Research International 2015 (2015): 1-13.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Cita MLA (9a ed.)
Urabe, Shigetoshi, et al. "Genetic Polymorphisms of IL-17F and TRAF3IP2 Could Be Predictive Factors of the Long-Term Effect of Infliximab Against Crohn's Disease."
BioMed Research International, vol. 2015, 2015, pp. 1-13.
Copiado correctamente al portapapeles
Error al copiar al portapapeles
Precaución: Estas citas no son 100% exactas.